# Overcoming the challenge of persistent left atrial appendage thrombosis: a case report of successful left atrial appendage occlusion using a cerebral protection system

**Authors:** Darko Althoff, Hannes Alessandrini, Jan-Per Wenzel, Roland Richard Tilz

PMC · DOI: 10.1093/ehjcr/ytag138 · European Heart Journal. Case Reports · 2026-03-04

## TL;DR

A patient with persistent heart condition and blood clot in the left atrial appendage successfully underwent a procedure to close it while protecting against stroke.

## Contribution

Demonstrates successful LAA occlusion with cerebral protection in a patient with persistent thrombosis despite anticoagulation.

## Key findings

- LAA occlusion with cerebral embolic protection was successfully performed in a patient with persistent LAA thrombosis.
- The patient showed normalization of left ventricular ejection fraction and sinus rhythm post-procedure.
- No severe adverse events were reported following the procedure.

## Abstract

Atrial fibrillation significantly increases the risk of ischaemic stroke, primarily due to left atrial appendage (LAA) thrombosis. Percutaneous left atrial appendage occlusion (LAAO) offers an alternative approach to oral anticoagulation. However, the presence of LAA thrombosis has been considered a contraindication due to the risk of cerebral embolization.

An 82-year-old woman presented to our department with dyspnoea and history of non-valvular persistent atrial fibrillation as well as heart failure. Serial transoesophageal echocardiography revealed persistent LAA thrombosis despite optimal oral anticoagulation. As a therapeutic alternative, percutaneous LAA closure with cerebral embolic protection was carried out successfully with no severe adverse events reported. In the following, the patient also underwent cryoballoon pulmonary vein isolation to achieve rhythm control. In the follow-up examination, the anticoagulation was replaced with aspirin and transthoracic echocardiography showed normalization of the left ventricular ejection fraction in sinus rhythm.

This case report illustrates that in highly selected patients with persistent LAA thrombus despite prolonged, optimized anticoagulation, LAAO performed under meticulous procedural precautions and cerebral embolic protection may represent a carefully justified, individualized bail-out strategy

## Linked entities

- **Diseases:** atrial fibrillation (MONDO:0004981), heart failure (MONDO:0005252), ischaemic stroke (MONDO:1060198)

## Full-text entities

- **Diseases:** atrial flutter (MESH:D001282), appendage (MESH:D018280), LAA occlusion (MESH:D059446), haemostasis (MESH:D020141), coronary artery disease (MESH:D003324), rheumatoid arthritis (MESH:D001172), ischaemic (MESH:D018917), cardiomyopathy (MESH:D009202), tachycardia (MESH:D013610), ischaemic stroke (MESH:D002544), bleeding (MESH:D006470), stroke (MESH:D020521), embolic (MESH:D004617), cardiac decompensation (MESH:D006333), thromboembolic (MESH:D013923), LAA thrombus (MESH:D013927), AF (MESH:D001281), cerebral embolization (MESH:D020766)
- **Chemicals:** heparin (MESH:D006493), CPS (-), apixaban (MESH:C522181), phenprocoumon (MESH:D010644), aspirin (MESH:D001241)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13007881/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13007881/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC13007881/full.md

---
Source: https://tomesphere.com/paper/PMC13007881